First Name

Last Name

Job Title

Company Name

What AI challenges are you trying to solve?

I need AI Infrastructure for training my model

I need AI Infrastructure for inference and finetuning my model

I need Inference-as-a-service with access to open-source models

Just exploring, I don’t know yet

What is your role in the buying process?

Final decision maker

Part of the evaluation team

Recommending solutions

Researching options

I’m not involved in the buying process

When are you planning to implement a solution?

Within 1–3 months

Within 3–6 months

6+ months

Just researching

By providing my contact information, I consent to Nebius using my personal data to send me marketing communications and to contact me by email or phone regarding its products and services. I understand that my consent is voluntary and may be withdrawn at any time.

Healthcare innovators and technology leaders discussed, in a roundtable organized by Nebius, AstraZeneca, and NVIDIA, opportunities for health systems to augment care delivery and reduce Potentially Avoidable Hospitalizations (PAHs) with AI.

This whitepaper summarizes expert insights on how growing medical data and AI capabilities help clinicians and nurses scale guideline-directed medical therapy (GDMT) across patient journeys to reduce PAHs.

Explore views on:

Innovating patient journeys with AI solutions to reduce potentially avoidable hospitalizations

AI’s potential to help care providers personalize treatments and extend specialist capabilities to the frontlines with case-specific analytics and clinically validated agentic and generative solutions.
Opportunities to advance implementation by addressing barriers around data availability, clinical adoption, system-wide incentives, and regulatory clarity.
Pathways for health systems, pharmaceutical leaders, tech companies, and policymakers to collaborate and enable AI-enhanced disease management.

Download Now!

Privacy Policy